Lynn Gold
General Counsel chez IPI LEGACY LIQUIDATION CO
Profil
Lynn Gold is currently the Senior Vice President-Regulatory Affairs at Impel Pharmaceuticals, Inc. Prior to this, she worked as the Vice President-Research & Process Development at Sonus Pharmaceuticals, Inc. and as the Vice President-CMC Services at Camargo Pharmaceutical Services LLC.
Dr. Gold holds a doctorate degree from the University of Rochester and an undergraduate degree from the State University of New York at Buffalo.
Postes actifs de Lynn Gold
| Sociétés | Poste | Début |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | General Counsel | 01/07/2018 |
Anciens postes connus de Lynn Gold
| Sociétés | Poste | Fin |
|---|---|---|
Camargo Pharmaceutical Services LLC
 Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | 01/06/2010 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - |
Formation de Lynn Gold
| Rochester Christian University | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Commercial Services |
